journal证据等级 B独立来源
证据页One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors (Niederwieser D, et al., Haematologica 107(5):1045-1053)
Haematologica
访问于 2026年9月20日更新 2026年9月20日
原始来源
https://pmc.ncbi.nlm.nih.gov/articles/PMC9052915/
pmc.ncbi.nlm.nih.gov
核验
| 核验 | 独立于主体的来源 |
| 证据等级 | B · 同行评审·专业机构 |
| 独立来源 | 与对象无关的独立来源 |
| 来源 | journal |
| 链接状态 | 最近检查时可访问 |
官方声明是服务方的陈述,除非另有标注,否则未经 worldwiki 验证。 来源政策
引用页面 (14)
AnswerIs stem cell therapy FDA approved?AnswerWhat conditions can stem cell therapy treat?AnswerWhat are the risks of stem cell therapy?AnswerHow do I know if a stem cell clinic is legitimate?AnswerIs stem cell therapy legal in South Korea?AnswerWhat is the difference between adult stem cells and embryonic stem cells?AnswerWhere are adult stem cells found in the body?AnswerWhat diseases are treated with adult stem cells?AnswerAre mesenchymal stem cell treatments FDA approved?AnswerSVF와 줄기세포의 차이는 무엇인가?Answer자가 줄기세포 의미와 종류는 무엇인가요?Answer줄기세포 의료, 현재 실제 치료에 쓰이는 분야는 어디까지인가요?ArticleStem Cell Therapy: Established Uses, Approved Products, Risks and How to Check a TreatmentArticleAdult Stem Cell (Somatic Stem Cell): Definition, Types, Established Uses and Evidence